Similar articles

• Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.

  Frost H, Swanborg RH. Frost H, et al. Int Arch Allergy Appl Immunol. 1980;63(2):153-8. doi: 10.1159/000232621. Int Arch Allergy Appl Immunol. 1980. PMID: 6158482
• Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.

  Hayosh NS, Simon LL, Swanborg RH. Hayosh NS, et al. J Immunol. 1984 Oct;133(4):1943-5. J Immunol. 1984. PMID: 6236261
• Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.

  Happ MP, Wettstein P, Dietzschold B, Heber-Katz E. Happ MP, et al. J Immunol. 1988 Sep 1;141(5):1489-94. J Immunol. 1988. PMID: 2457618
• Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.

  Wegmann KW, Hinrichs DJ. Wegmann KW, et al. J Immunol. 1984 May;132(5):2417-23. J Immunol. 1984. PMID: 6201543
• LT/EAE and the MS quest. Going to the dogs and rats to study the patient.

  Paterson PY. Paterson PY. Cell Immunol. 1983 Nov;82(1):55-74. doi: 10.1016/0008-8749(83)90140-5. Cell Immunol. 1983. PMID: 6196130 Review. No abstract available.